LHC Group (NASDAQ:LHCG) Cut to Buy at BidaskClub

BidaskClub cut shares of LHC Group (NASDAQ:LHCG) from a strong-buy rating to a buy rating in a research report released on Tuesday morning, BidAskClub reports.

A number of other research firms have also recently issued reports on LHCG. Craig Hallum lifted their target price on shares of LHC Group from $93.00 to $114.00 and gave the company a hold rating in a research note on Friday, March 1st. They noted that the move was a valuation call. SunTrust Banks lifted their target price on shares of LHC Group to $130.00 and gave the company a buy rating in a research note on Friday, March 1st. Robert W. Baird lifted their target price on shares of LHC Group from $98.00 to $120.00 and gave the company a neutral rating in a research note on Monday, March 4th. Barclays lifted their target price on shares of LHC Group from $95.00 to $104.00 and gave the company an equal weight rating in a research note on Thursday, March 21st. Finally, Zacks Investment Research cut shares of LHC Group from a buy rating to a hold rating in a research note on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of Buy and an average target price of $120.58.

NASDAQ LHCG opened at $116.50 on Tuesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. The company has a market cap of $3.63 billion, a price-to-earnings ratio of 32.82, a P/E/G ratio of 1.96 and a beta of 0.83. LHC Group has a 1-year low of $80.84 and a 1-year high of $122.20.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, May 8th. The health services provider reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.08. The company had revenue of $502.59 million for the quarter, compared to the consensus estimate of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. On average, sell-side analysts predict that LHC Group will post 4.3 EPS for the current year.

In related news, CEO Keith G. Myers sold 5,164 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $108.75, for a total value of $561,585.00. Following the completion of the transaction, the chief executive officer now owns 96,315 shares in the company, valued at approximately $10,474,256.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronald T. Nixon sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total transaction of $1,406,400.00. Following the completion of the transaction, the director now owns 29,100 shares of the company’s stock, valued at approximately $3,410,520. The disclosure for this sale can be found here. Insiders sold a total of 62,991 shares of company stock valued at $7,134,055 in the last 90 days. 5.20% of the stock is currently owned by corporate insiders.

Hedge funds have recently bought and sold shares of the stock. Citigroup Inc. raised its position in LHC Group by 265.2% in the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after purchasing an additional 3,185 shares during the last quarter. Everence Capital Management Inc. raised its position in shares of LHC Group by 43.6% during the 1st quarter. Everence Capital Management Inc. now owns 4,050 shares of the health services provider’s stock valued at $449,000 after acquiring an additional 1,230 shares during the last quarter. Campbell Newman Asset Management Inc. raised its position in shares of LHC Group by 2.4% during the 1st quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock valued at $704,000 after acquiring an additional 151 shares during the last quarter. Financial Gravity Companies Inc. bought a new stake in shares of LHC Group during the 4th quarter valued at $49,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of LHC Group during the 4th quarter valued at $695,000. Hedge funds and other institutional investors own 91.42% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: What is a blue-chip stock?

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.